Evidence map›Paper›PMID 27647178›Full record

ArticleDiabetic medicine : a journal of the British Diabetic Association2017

Risk of future microvascular and macrovascular disease in people with Type 1 diabetes of very long duration: a national study with 10-year follow-up.

S Adamsson Eryd, A-M Svensson, S Franzén, B Eliasson, P M Nilsson, S Gudbjörnsdottir

Open access · bronzeAbstract read
In one paragraph

Article in Diabetic medicine : a journal of the British Diabetic Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Early Vascular Aging in Hypertension.Frontiers in cardiovascular medicine · 2020
    Review
  18. Achieving Good Glycemic Control Early After Onset of Diabetes: A Cost-Effectiveness Analysis in Patients with Type 1 Diabetes in Sweden.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2018
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

S Adamsson ErydNational Diabetes Register, Centre of Registers Västra Götaland, Gothenburg, Sweden.
A-M SvenssonNational Diabetes Register, Centre of Registers Västra Götaland, Gothenburg, Sweden.
S FranzénNational Diabetes Register, Centre of Registers Västra Götaland, Gothenburg, Sweden.
B EliassonDepartment of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden.
P M NilssonDepartment of Clinical Sciences, Skåne University Hospital, Lund University, Malmö, Sweden.
S GudbjörnsdottirNational Diabetes Register, Centre of Registers Västra Götaland, Gothenburg, Sweden.
Centre of Registers Vastra Gotaland · SEUniversity of Gothenburg · SESahlgrenska University Hospital · SESkåne University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo describe factors associated with prevalence or absence of microvascular and macrovascular complications in people with Type 1 diabetes of very long duration and to investigate the risk factors associated with the incidence of such complications.

methodsWe included individuals with Type 1 diabetes who had been entered in the Swedish National Diabetes Register between 2002 and 2004 (n = 18 450). First, risk factor distribution in people with diabetes duration of ≥ 50 years was compared between people with and without complications. Second, the incidence of complications during a 10-year follow-up period was studied in all individuals who had no complications at baseline.

resultsAmong people with a diabetes duration of ≥ 50 years (n = 1023), 453 (44%) had macrovascular disease, 534 (52%) had microvascular disease and 319 (31%) did not have either of the diagnoses. Factors that differed significantly between people with and without macrovascular disease were gender, age, HbA

conclusionsPeople with Type 1 diabetes who have survived ≥ 50 years without complications are significantly younger, and have significantly lower HbA

Indexed as

AgingAdolescentAdultAgedCohort StudiesDiabetes Mellitus, Type 1Diabetic AngiopathiesDisease ProgressionFemaleFollow-Up StudiesGlycated HemoglobinHumansHyperglycemiaIncidenceMaleMicrovesselsGlycated Hemoglobinhemoglobin A1c protein, human

Identifiers

PMID27647178
PMCPMC5516128
OpenAlexW2521772333

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.